Planned sale of 1,000 shares disclosed in notice

Brett Sandercock filed a notice of proposed sale of 1,000 shares of common stock with an aggregate market value of 257,030.00, to be sold through Fidelity Brokerage Services LLC on the NYSE around 02/02/2026.

Accepted by SEC EDGAR 02/02/2026 - 03:15 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Brett Sandercock filed a notice of proposed sale of 1,000 shares of common stock with an aggregate market value of 257,030.00, to be sold through Fidelity Brokerage Services LLC on the NYSE around 02/02/2026.

The 1,000 shares were acquired on 11/11/2022 through restricted stock vesting from the issuer as compensation. Over the prior three months, Brett Sandercock sold 3,000 common shares on 11/03/2025 for gross proceeds of 742,620.00, 1,000 shares on 12/01/2025 for 244,160.00, and 1,000 shares on 01/02/2026 for 241,750.00.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the latest Form 144 filing related to RMD disclose?

The notice discloses a planned sale of 1,000 common shares with an aggregate market value of 257,030.00 through Fidelity Brokerage Services LLC on the NYSE, with the seller identified as Brett Sandercock and the approximate sale date of 02/02/2026.

How many RMD shares is Brett Sandercock proposing to sell under this Form 144?

Brett Sandercock proposes to sell 1,000 common shares. The filing lists these shares with an aggregate market value of 257,030.00, to be sold through Fidelity Brokerage Services LLC on the NYSE, with an approximate sale date of 02/02/2026.

How and when were the 1,000 RMD shares being sold originally acquired?

The 1,000 shares were acquired on 11/11/2022 via restricted stock vesting from the issuer. The filing classifies the acquisition’s nature as compensation, with the same date listed as the payment date and the amount of securities acquired shown as 1,000 shares.

What RMD share sales has Brett Sandercock made in the past three months?

The filing lists three sales: 3,000 common shares on 11/03/2025 for gross proceeds of 742,620.00, 1,000 shares on 12/01/2025 for 244,160.00, and 1,000 shares on 01/02/2026 for 241,750.00, all attributed to Brett Sandercock.

On which exchange are the RMD shares in this Form 144 planned to be sold?

The proposed sale is listed for the NYSE. The filing specifies that 1,000 common shares with an aggregate market value of 257,030.00 are to be sold through Fidelity Brokerage Services LLC on the NYSE around 02/02/2026.

Who is the broker named in the RMD-related Form 144 filing?

The broker named is Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917. The filing associates this broker with the planned sale of 1,000 common shares valued in aggregate at 257,030.00 on the NYSE.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001346064
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	RESMED INC
SEC File Number	001-15317
Address of Issuer	9001 SPECTRUM CENTER BLVD. SAN DIEGO CALIFORNIA 92123
Phone	8587462400
Name of Person for Whose Account the Securities are To Be Sold	Sandercock Brett
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1000	257030.00	145678401	02/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/11/2022	Restricted Stock Vesting	Issuer			1000	11/11/2022	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Brett Sandercock 9001 Spectrum Center Blvd San Diego CA 92123	Common	11/03/2025	3000	742620.00
Brett Sandercock 9001 Spectrum Center Blvd San Diego CA 92123	Common	12/01/2025	1000	244160.00
Brett Sandercock 9001 Spectrum Center Blvd San Diego CA 92123	Common	01/02/2026	1000	241750.00

144: Remarks and Signature

Remarks
Date of Notice	02/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/19/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Brett Sandercock
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)